{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:22:43Z","timestamp":1792650163526,"version":"4.5.0"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T00:00:00Z","timestamp":1639440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>TB continues to be one of the major public health threats. BCG is the only available vaccine against TB and confers significant protection against the childhood disease. However, the protective efficacy of BCG against adult pulmonary TB, which represents a larger burden of disease, is highly variable. It has been suggested that prior exposure to environmental mycobacteria (EMb) mitigates the anti-TB efficacy of BCG by blocking its duplication or masking its immunogenicity. However, its effectiveness against childhood TB and failure of repeated administration to provide additional benefit against pulmonary TB, suggest of some other mechanisms for the variable efficacy of BCG against the pulmonary disease. Importantly, TB is a heterogeneous disease occurring in different forms and having distinct mechanisms of pathogenesis. While inability of the immune system to contain the bacilli is responsible for TB pathogenesis in infants, an aggravated immune response to<jats:italic>Mtb<\/jats:italic>has been blamed for the development of adult pulmonary TB. Available data suggest that EMb play a key role in heightening the immune response against<jats:italic>Mtb<\/jats:italic>. In this article, differential efficacy of BCG against childhood and adult TB is explained by taking into account the heterogeneity of TB, mechanisms of TB pathogenesis, and the effect of EMb on anti-<jats:italic>Mtb<\/jats:italic>immunity. It is believed that a refined understanding of the success and failure of BCG will help in the development of effective anti-TB vaccines.<\/jats:p>","DOI":"10.3389\/fimmu.2021.778028","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T08:22:06Z","timestamp":1639470126000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":38,"title":["A Perspective on the Success and Failure of BCG"],"prefix":"10.3389","volume":"12","author":[{"given":"Pawan","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrmicro1211","article-title":"Opinion: The Success and Failure of BCG\u2013Implications for a Novel Tuberculosis Vaccine. Nature Reviews","volume":"3","author":"Andersen","year":"2005","journal-title":"Microbiology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01134","article-title":"What Have We Learnt About BCG Vaccination in the Last 20\u2009Years","volume":"8","author":"Dockrell","year":"2017","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","article-title":"The Immune Response in Tuberculosis","volume":"31","author":"O\u2019Garra","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"B4","article-title":"History of BCG Vaccine","volume":"8","author":"Luca","year":"2013","journal-title":"Maedica"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in Protection by BCG: Implications of and for Heterologous Immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1164\/arrd.1966.94.4.553","article-title":"Effects of Infection With Atypical Mycobacteria on BCG Vaccination and Tuberculosis","volume":"94","author":"Palmer","year":"1966","journal-title":"Am Rev Respir Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.2.672-678.2002","article-title":"Failure of the Mycobacterium Bovis BCG Vaccine: Some Species of Environmental Mycobacteria Block Multiplication of BCG and Induction of Protective Immunity to Tuberculosis","volume":"70","author":"Brandt","year":"2002","journal-title":"Infect Immun"},{"key":"B8","article-title":"What has Karonga Taught Us? Tuberculosis Studied Over Three Decades","volume":"13","author":"Crampin","year":"2009","journal-title":"Int J Tuberc Lung Dis: Off J Int Union Against Tuberc Lung Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(21)00309-0","article-title":"BCG Re-Vaccination in Malawi: 30-Year Follow-Up of a Large, Randomised, Double-Blind, Placebo-Controlled Trial","volume":"9","author":"Glynn","year":"2021","journal-title":"Lancet Global Health"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01987.x","article-title":"Exposure to Mycobacterium Avium Primes the Immune System of Calves for Vaccination With Mycobacterium Bovis BCG","volume":"130","author":"Howard","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2007.12.002","article-title":"Consequence of Prior Exposure to Environmental Mycobacteria on BCG Vaccination and Diagnosis of Tuberculosis Infection","volume":"88","author":"Thom","year":"2008","journal-title":"Tuberc (Edinburgh Scotland)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.4.2190-2196.2005","article-title":"Differential Effects of Prior Exposure to Environmental Mycobacteria on Vaccination With Mycobacterium Bovis BCG or a Recombinant BCG Strain Expressing RD1 Antigens","volume":"73","author":"Demangel","year":"2005","journal-title":"Infect Immun"},{"key":"B13","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/imr.12252","article-title":"Heterogeneity in Tuberculosis Pathology, Microenvironments and Therapeutic Responses","volume":"264","author":"Lenaerts","year":"2015","journal-title":"Immunol Rev"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20052302","article-title":"Tuberculosis in Children and Adults","volume":"202","author":"Alca\u00efs","year":"2005","journal-title":"J Exp Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"a017855","DOI":"10.1101\/cshperspect.a017855","article-title":"Tuberculosis in Children","volume":"4","author":"Marais","year":"2014","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-017-0654-9","article-title":"Vaccine Responses in Newborns","volume":"39","author":"Saso","year":"2017","journal-title":"Semin Immunopathol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.6.2820","article-title":"Differential Patterns of Methylation of the IFN-Gamma Promoter at CpG and Non-CpG Sites Underlie Differences in IFN-Gamma Gene Expression Between Human Neonatal and Adult CD45RO- T Cells","volume":"168","author":"White","year":"2002","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40169-017-0151-8","article-title":"Ifn\u03b3-Producing CD4+ T Lymphocytes: The Double-Edged Swords in Tuberculosis","volume":"6","author":"Kumar","year":"2017","journal-title":"Clin Trans Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40169-016-0119-0","article-title":"Adult Pulmonary Tuberculosis as a Pathological Manifestation of Hyperactive Antimycobacterial Immune Response","volume":"5","author":"Kumar","year":"2016","journal-title":"Clin Trans Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00120908","article-title":"LTBI: Latent Tuberculosis Infection or Lasting Immune Responses to M. Tuberculosis? A TBNET Consensus Statement","volume":"33","author":"Mack","year":"2009","journal-title":"Eur Respir J"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy265","article-title":"Risk and Timing of Tuberculosis Among Close Contacts of Persons With Infectious Tuberculosis","volume":"218","author":"Reichler","year":"2018","journal-title":"J Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.2.704-706.2002","article-title":"Immune Responses to the Mycobacterium Tuberculosis-Specific Antigen ESAT-6 Signal Subclinical Infection Among Contacts of Tuberculosis Patients","volume":"40","author":"Doherty","year":"2002","journal-title":"J Clin Microbiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1146\/annurev.immunol.22.012703.104635","article-title":"Immunity to Tuberculosis","volume":"22","author":"North","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2017.03.028","article-title":"Original Mycobacterial Sin, A Consequence of Highly Homologous Antigens","volume":"203","author":"Jenkins","year":"2017","journal-title":"Vet Microbiol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/S0954-6111(96)80006-0","article-title":"Skin Anergy and Tuberculosis","volume":"86","author":"Maher","year":"1992","journal-title":"Respir Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu446","article-title":"Tuberculin Skin Test Negativity Is Under Tight Genetic Control of Chromosomal Region 11p14-15 in Settings With Different Tuberculosis Endemicities","volume":"211","author":"Cobat","year":"2015","journal-title":"J Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000202648.18526.bf","article-title":"Explosion of Tuberculin-Specific Th1-Responses Induces Immune Restoration Syndrome in Tuberculosis and HIV Co-Infected Patients","volume":"20","author":"Bourgarit","year":"2006","journal-title":"Aids"},{"key":"B28","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1186\/s12879-020-05225-x","article-title":"Prevalence and Risk Factors of Paradoxical Tuberculosis Associated Immune Reconstitution Inflammatory Syndrome Among HIV-Infected Patients in Beijing, China","volume":"20","author":"Xue","year":"2020","journal-title":"BMC Infect Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-286336","article-title":"Th1-Driven Immune Reconstitution Disease in Mycobacterium Avium\u2013Infected Mice","volume":"116","author":"Barber","year":"2010","journal-title":"Blood"},{"key":"B30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/82_2010_116","article-title":"Role of PD-1 in Regulating T-Cell Immunity","volume":"350","author":"Jin","year":"2011","journal-title":"Curr Topics Microbiol Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1007394107","article-title":"Programmed Death-1 (PD-1)\u2013Deficient Mice Are Extraordinarily Sensitive to Tuberculosis","volume":"107","author":"L\u00e1z\u00e1r-Moln\u00e1r","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e1005667","DOI":"10.1371\/journal.ppat.1005667","article-title":"CD4 T Cell-Derived IFN-\u03b3 Plays a Minimal Role in Control of Pulmonary Mycobacterium Tuberculosis Infection and Must be Actively Repressed by PD-1 to Prevent Lethal Disease","volume":"12","author":"Sakai","year":"2016","journal-title":"PloS Pathog"},{"key":"B33","doi-asserted-by":"publisher","first-page":"eaat2702","DOI":"10.1126\/scitranslmed.aat2702","article-title":"Tuberculosis Following PD-1 Blockade for Cancer Immunotherapy","volume":"11","author":"Barber","year":"2019","journal-title":"Sci Trans Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200409-1200OC","article-title":"Rate of Reinfection Tuberculosis After Successful Treatment Is Higher Than Rate of New Tuberculosis","volume":"171","author":"Verver","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"B35","article-title":"Effector Memory T-Cells Dominate Immune Responses in Tuberculosis Treatment: Antigen or Bacteria Persistence","volume":"14","author":"Tapaninen","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1086\/323044","article-title":"Long-Lived Immune Response to Early Secretory Antigenic Target 6 in Individuals Who had Recovered From Tuberculosis","volume":"33","author":"Wu-Hsieh","year":"2001","journal-title":"Clin Infect Dis"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.233.123","article-title":"Persistently Retained Interferon-Gamma Responsiveness in Individuals With a History of Pulmonary Tuberculosis","volume":"233","author":"Seo","year":"2014","journal-title":"Tohoku J Exp Med"},{"key":"B38","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.163.4.2249","article-title":"Newborns Develop a Th1-Type Immune Response to Mycobacterium Bovis Bacillus Calmette-Guerin Vaccination","volume":"163","author":"Marchant","year":"1999","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200105)31:5<1531::AID-IMMU1531>3.0.CO;2-1","article-title":"Neonatal Bacillus Calmette-Guerin Vaccination Induces Adult-Like IFN-Gamma Production by CD4+ T Lymphocytes","volume":"31","author":"Vekemans","year":"2001","journal-title":"Eur J Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2002.01366.x","article-title":"Neonatal Mycobacterial Specific Cytotoxic T-Lymphocyte and Cytokine Profiles in Response to Distinct BCG Vaccination Strategies","volume":"105","author":"Hussey","year":"2002","journal-title":"Immunology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.2.919","article-title":"Influence of Mycobacterium Bovis Bacillus Calmette-Gu\u00e9rin on Antibody and Cytokine Responses to Human Neonatal Vaccination","volume":"168","author":"Ota","year":"2002","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.8.5647","article-title":"Bacillus Calmette Guerin Vaccination of Human Newborns Induces a Specific, Functional CD8+ T Cell Response","volume":"177","author":"Murray","year":"2006","journal-title":"J Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.5.3569","article-title":"Bacillus Calmette-Gu\u00e9rin Vaccination of Human Newborns Induces T Cells With Complex Cytokine and Phenotypic Profiles","volume":"180","author":"Soares","year":"2008","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e77334","DOI":"10.1371\/journal.pone.0077334","article-title":"The Contribution of non-Conventional T Cells and NK Cells in the Mycobacterial-Specific Ifn\u03b3 Response in Bacille Calmette-Gu\u00e9rin (BCG)-Immunized Infants","volume":"8","author":"Zufferey","year":"2013","journal-title":"PloS One"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/587315","article-title":"\u03b3\u03b4 T Cells Cross-Link Innate and Adaptive Immunity in Mycobacterium Tuberculosis Infection","volume":"2011","author":"Meraviglia","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis941","article-title":"Longitudinal Changes in CD4(+) T-Cell Memory Responses Induced by BCG Vaccination of Newborns","volume":"207","author":"Soares","year":"2013","journal-title":"J Infect Dis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"15309","DOI":"10.1038\/s41598-018-33499-4","article-title":"Age-Related Waning of Immune Responses to BCG in Healthy Children Supports the Need for a Booster Dose of BCG in TB Endemic Countries","volume":"8","author":"Whittaker","year":"2018","journal-title":"Sci Rep"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.06.103","article-title":"Delaying BCG Vaccination From Birth to 10 Weeks of Age May Result in an Enhanced Memory CD4 T Cell Response","volume":"27","author":"Kagina","year":"2009","journal-title":"Vaccine"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e2014043","DOI":"10.4084\/mjhid.2014.043","article-title":"Tuberculosis in Tropical Areas and Immigrants","volume":"6","author":"Zammarchi","year":"2014","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"B50","first-page":"1","article-title":"Tuberculosis Prevention Trial, Madras","author":"Baily","year":"1980","journal-title":"Indian J Med Res"},{"key":"B51","article-title":"Trial of BCG Vaccines in South India for Tuberculosis Prevention: First Report","volume":"57","author":"Trial","year":"1979","journal-title":"Bull World Health Organ"},{"key":"B52","first-page":"459","article-title":"Tuberculosis in Tropical Africa. An Epidemiological Study","volume":"30","author":"Roelsgaard","year":"1964","journal-title":"Bull World Health Organ"},{"key":"B53","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0007-0971(86)90007-0","article-title":"Tuberculin Reactivity in a Chest Clinic: The Effects of Age and Prior BCG Vaccination","volume":"80","author":"Capewell","year":"1986","journal-title":"Br J Dis Chest"},{"key":"B54","first-page":"5","article-title":"The Efficacy of the Tuberculin Test: An Analysis Based on Results From 33 Countries","volume":"22","author":"Nyboe","year":"1960","journal-title":"Bull World Health Organ"},{"key":"B55","first-page":"1","article-title":"An Atlas of Sensitivity to Tuberculin, PPD-B, and Histoplasmin in the United States","volume":"99","author":"Edwards","year":"1969","journal-title":"Am Rev Respir Dis"},{"key":"B56","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0041-3879(85)90048-0","article-title":"Species Level Identification of Non-Tuberculous Mycobacteria From South Indian BCG Trial Area During 1981","volume":"66","author":"Paramasivan","year":"1985","journal-title":"Tubercle"},{"key":"B57","doi-asserted-by":"publisher","first-page":"44","DOI":"10.12927\/whp.2008.19785","article-title":"Population-Based Tuberculin Skin Testing and Prevalence of Tuberculosis Infection in Afghanistan","volume":"10","author":"Doocy","year":"2008","journal-title":"World Health Popul"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.64.3.283","article-title":"Evaluation of BCG Vaccination Among Puerto Rican Children","volume":"64","author":"Comstock","year":"1974","journal-title":"Am J Public Health"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90794-4","article-title":"Efficacy of BCG Vaccine Against Leprosy and Tuberculosis in Northern Malawi","volume":"339","author":"P\u00f6nnighaus","year":"1992","journal-title":"Lancet (London England)"},{"key":"B60","article-title":"Case-Control Study of BCG Vaccination as a Risk Factor for Leprosy and Tuberculosis in Western Kenya","volume":"61","author":"Orege","year":"1993","journal-title":"Int J Lepr Other Mycobact Dis: Off Organ Int Lepr Assoc"}],"updated-by":[{"DOI":"10.3389\/fimmu.2022.850325","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000}}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.778028\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T08:13:50Z","timestamp":1674029630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.778028\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,14]]},"references-count":60,"alternative-id":["10.3389\/fimmu.2021.778028"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.778028","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fimmu.2022.850325","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,14]]},"article-number":"778028"}}